Clinical Guidelines & Documents
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients
In view of the increasing complexity of both cardiovascular implantable electronic devices (CIEDs) and patients in the current era, practice guidelines, by necessity, have become increasingly specific. This document is an expert consensus statement that has been developed to update and further delineate indications and management of CIEDs in pediatric patients, defined as ≤21 years of age, and is intended to focus primarily on the indications for CIEDs in the setting of specific disease categories.2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary
Document Reviewers: Philip M. Chang, MD, FHRS, FACC; Fabrizio Drago, MD, FAIAC; Anne M. Dubin, MD, FHRS; Susan P. Etheridge, MD, FHRS; Apichai Kongpatanayothin, MD, FAsCC; Jose Manuel Moltedo, MD, FACC; Ashish A. Nabar, MD, DNB, PhD, FISE; George F. Van Hare, MD, FHRS, FACC, FAAPPACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease
In 2002, an expert consensus statement was published on catheter ablation in children and adults with congenital heart disease (CHD), based on a conference held at the North American Society of Pacing and Electrophysiology in the year 2000.1 Since publication in 2002, numerous technological improvements have been introduced, including catheter cryoablation, 3-dimensional (3D) mapping, percutaneous epicardial ablation, and high-powered ablation catheters using passive or active tip cooling. In addition, the uses of catheter ablation in pediatrics have expanded to include the management of virtually every arrhythmia, including atrial fibrillation (AF).
